KAYLEIGH LAUREN GUADAGNOLI
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner PUEBLO, CO NPI 1295595189
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner CO Novo Nordisk AS All categories
General Payments — all program years on this page
$136.79
- Category: General Payments
- Program years: PY2024
- Record count: 7
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $136.79 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $136.79 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $79.19 | 4 |
| Bayer HealthCare Pharmaceuticals Inc. | $25.89 | 1 |
| Acerta Pharma LLC | $18.28 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.43 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $136.79 | 7 |
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086370469 | Bayer Healthcare Pharmaceuticals Inc. | $25.89 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100255258 | Novo Nordisk Inc | $16.29 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100271622 | Novo Nordisk Inc | $17.06 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100336857 | Novo Nordisk Inc | $20.91 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100644239 | Novo Nordisk Inc | $24.93 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105574446 | AstraZeneca Pharmaceuticals LP | $18.28 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153511833 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.43 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.